Please login to the form below

Not currently logged in
Email:
Password:

Janssen’s Leisha Daly appointed VP of IPHA

Joins Irish trade body for pharma as plan to cut country’s drug prices agreed

Leisha Daly, IPHAThe Irish Pharmaceutical Healthcare Association (IPHA) has appointed Janssen's Dr Leisha Daly as vice president.

Dr Daly, who serves as country director at Janssen, joins the trade body at a crucial time for the pharma industry in Ireland, with the IPHA this week agreeing plans with the Department of Health and Health Service Executive (HSE) to cut the price of hundreds of medicines by an average of 10 per cent.

She takes over from Pfizer's David Gallagher as vice president, following his two years in the position, and will serve alongside fellow vice president Dr Neil Boyle of MSD.

In addition to her role at Janssen, Dr Daly has served on the IPHA board of directors since June, 2012, and was appointed to the prescription medicines division strategy board in August, 2012.

Dr Daly joined Janssen in 1998 as head of technical affairs, rising up the ranks to hold a variety of senior positions in medical, sales and marketing, before being appointed to her current position in March, 2012.

Prior to joining Janssen, Dr Daly served at Hoechst Ireland having spent several years in academic clinical research.

25th October 2012

From: Research, Sales, Regulatory

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Porterhouse Medical Group

The Porterhouse Medical Group provides market research, insights, and scientific and medical communication services to the pharmaceutical industry across the...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics